Nerlynx
- Product NDC
- 70437-240
- 11-digit product format
- 704370240
- Labeler code
- 70437
- Product ID
- 70437-240_44eb88a3-0ac0-2880-e063-6394a90af02f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- neratinib
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Puma Biotechnology, Inc.
- Application
- NDA208051
- Marketing category
- NDA
- Marketing start
- 2017-07-17
- Substance
- NERATINIB MALEATE ANHYDROUS
- Active strength
- 40 mg/1
- Pharmacologic classes
- Kinase Inhibitor [EPC], Kinase Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Nerlynx
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| NERATINIB MALEATE ANHYDROUS | 40 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 9RM7XY23ZS |
| Rxcui | 1940648, 1940654 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70437-240 | NERLYNX (NERATINIB) TABLET [PUMA BIOTECHNOLOGY, INC.] | 17 | Current NDC, Legacy NDC, 6 package rows | 20240327_d1e41dcf-e82a-47c2-a0ad-6c6eef621834.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70437-240-18 | 70437024018 | 1 BOTTLE in 1 BOX (70437-240-18) / 180 TABLET in 1 BOTTLE | 1 bottle | 2017-07-17 | 0000-00-00 | No | No | Current |
| 70437-240-26 | 70437024026 | 1 BOTTLE in 1 BOX (70437-240-26) / 126 TABLET in 1 BOTTLE | 1 bottle | 2017-07-17 | 0000-00-00 | No | No | Current |
| 70437-240-33 | 70437024033 | 1 BOTTLE in 1 BOX (70437-240-33) / 133 TABLET in 1 BOTTLE | 1 bottle | 2017-07-17 | 0000-00-00 | No | No | Current |